In the presence of treatment effect heterogeneity, the average treatment effect (ATE) in a randomized controlled trial (RCT) may differ from the average effect of the same treatment if applied to a target population of interest. But for policy purposes we may desire an estimate of the target population ATE. If all treatment effect moderators are observed in the RCT and in a dataset representing the target population, then we can obtain an estimate for the target population ATE by adjusting for the difference in the distribution of the moderators between the two samples.However, that is often an unrealistic assumption in practice.This talk will discuss methods for generalizing treatment effects under that assumption, as well as sensitivity analyses for when we cannot adjust for a specific moderator.